Xenohelix
Xenohelix is a biotech company in Incheon, South Korea, founded in 2019. It has 1 recorded funding round, most recently a Seed in September 2019.
제노헬릭스
- Headquarters
- Incheon
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- xenohelix.com
- Last Round
- SeedSep 2019
- Rounds
- 1
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Xenohelix (제노헬릭스) is a South Korean biotech company specializing in small RNA (sRNA) platform technology for molecular diagnostics and research. The company develops ultra-sensitive RNA detection platforms including XENOPURE for high-purity RNA extraction and XENO-Q for single-base-pair precision diagnostics, targeting conditions such as Parkinson's disease and fatty liver disease. Its technology enables non-invasive, blood-based early diagnosis as an alternative to expensive conventional tests, and the company also offers cosmetic products derived from natural exosomes.
Summary
It lists 11–50 employees. Its most recent funding was a Seed round in Sep 2019. Investors include KB Investment and Partners Investment.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2019
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/xenohelix"><img src="https://indexed.vc/api/badge/company/xenohelix" alt="Xenohelix on Indexed.vc" width="260" height="76" /></a>